VitD/Dexa treatment also reduced the percentage of IFNγ+ CD8+ T cells (Figure 5A, right panel), which have been recently suggested as promoters of atherosclerosis by controlling monopoiesis and circulating monocytes (28). This evidence concerns the gene IFNG and atherosclerosis.